GAG
LLY icon

GM Advisory Group’s Eli Lilly LLY Stock Holding History

GM Advisory Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.2M Buy
10,002
+273
+3% +$277K 0.35% 48
2025
Q4 		$10.5M Sell
9,729
-2,375
-20% -$2.27M 0.41% 45
2025
Q3 		$9.24M Sell
12,104
-626
-5% -$466K 0.39% 48
2025
Q2 		$9.92M Buy
12,730
+792
+7% +$615K 0.49% 43
2025
Q1 		$9.86M Buy
11,938
+552
+5% +$459K 0.53% 35
2024
Q4 		$8.79M Buy
11,386
+397
+4% +$329K 0.49% 42
2024
Q3 		$9.74M Buy
10,989
+284
+3% +$255K 0.58% 34
2024
Q2 		$9.69M Buy
10,705
+89
+0.8% +$71.2K 0.63% 34
2024
Q1 		$8.26M Buy
10,616
+448
+4% +$319K 0.58% 33
2023
Q4 		$5.93M Sell
10,168
-361
-3% -$211K 0.45% 37
2023
Q3 		$5.66M Sell
10,529
-440
-4% -$227K 0.46% 32
2023
Q2 		$5.14M Sell
10,969
-1,374
-11% -$576K 0.43% 33
2023
Q1 		$4.24M Buy
12,343
+1,107
+10% +$373K 0.39% 37
2022
Q4 		$4.11M Hold
11,236
– – 0.44% 31
2022
Q3 		$3.63M Hold
11,236
– – 0.46% 25
2022
Q2 		$3.64M Buy
11,236
+1,507
+15% +$452K 0.57% 30
2022
Q1 		$2.79M Sell
9,729
-362
-4% -$93.2K 0.33% 48
2021
Q4 		$2.79M Buy
10,091
+244
+2% +$61.9K 0.25% 57
2021
Q3 		$2.27M Sell
9,847
-550
-5% -$136K 0.23% 56
2021
Q2 		$2.39M Sell
10,397
-948
-8% -$190K 0.24% 58
2021
Q1 		$2.12M Sell
11,345
-571
-5% -$112K 0.25% 54
2020
Q4 		$2.01M Buy
11,916
+1,733
+17% +$259K 0.27% 47
2020
Q3 		$1.51M Hold
10,183
– – 0.23% 52
2020
Q2 		$1.67M Sell
10,183
-4,117
-29% -$632K 0.31% 49
2020
Q1 		$1.98M Buy
+14,300
New +$1.96M 0.54% 32

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

GM Advisory Group's LLY Position: Q1 2026 in Review

GM Advisory Group increased its Eli Lilly (LLY) stake by 2.8% in Q1 2026, buying an estimated $277K and bringing the position to 10,002 shares worth $9.2M. The position accounts for 0.35% of the portfolio, ranked #48.

GM Advisory Group first reported a position in LLY in Q1 2020 and has held it in 25 quarters since. The position peaked at $10.5M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • GM Advisory Group held 10,002 shares of Eli Lilly worth $9.2M as of Q1 2026.
  • GM Advisory Group bought 273 Eli Lilly shares in Q1 2026, an estimated $277K.
  • Eli Lilly made up 0.35% of GM Advisory Group's portfolio in Q1 2026, its #48 holding.
  • GM Advisory Group first reported a position in Eli Lilly in Q1 2020 and has held it in 25 quarters since.
  • GM Advisory Group's Eli Lilly position peaked at $10.5M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on GM Advisory Group's 13F filing for Q1 2026, filed 28 Apr 2026.